
Capital Markets
Mergers and Acquisitions
Initial Public Offerings
Healthcare
Technology
Private Equity
Venture Capital
Dr. Mengyu Lu is a Partner at Kirkland & Ellis, based in Hong Kong. She leads the firm's Asia capital markets practice, specializing in initial public offerings, SPACs, pre-IPO financings, mergers and acquisitions, and compliance matters for listed companies. Dr. Lu is highly regarded for her expertise in the 'new economy' sectors, including healthcare, semiconductor, artificial intelligence, TMT, and consumer sectors. She advises both corporate issuers and major investment banks, private equity, and venture capital firms on capital markets and M&A matters. Recognized by Chambers Global and Legal 500, Dr. Lu is a leading figure in China equity capital markets.
Dr. Mengyu Lu's representative experience includes advising:

- NovaBridge Biosciences acquired the target/assets from AffaMed Therapeutics (HK) Limited in a acquisition on not available. - Deal value was 3500000000 Sector: Biotechnology; Location: Global. - On the acquirer side, counsel was not available, led by Mengyu Lu, Jiayi Wang, Justin Zhou, Ryan Choi, Yuchen Han, Louis Zhou, Rock Liu.
Nov 05 2025
4B
Private Equity

Partner
2021 – Unknown
Partner
2014 – 2015
Associate
2011 – 2014

Partner
2015 – 2021

- Edding Group Company Limited acted as the acquirer in this Merger transaction. - The acquisition targeted assets operating in the Biopharmaceuticals sector. - The transaction was announced on 07 Oct 2024 with a reported value of 12000000000.0.
Oct 07 2024
12B
M&A
Kirkland & Ellis represented the joint sponsors, including Morgan Stanley Asia Limited, CITIC Securities (Hong Kong) Limited and Goldman Sachs (Asia) L.L.C., on the initial public offering of Muyuan Foods Co., Ltd. (Muyuan, SZ: 002714, HKEX: 2714) on the Main Board of The Stock Exchange of Hong Kong Limited on February 6, 2026. Muyuan, a leading pork company pioneering smart hog farming, successfully offered 273,951,400 H Shares at an initial public offering price of HK$39.00 per share and raised approximately HK$10.68 billion prior to the exercise of the 15% over-allotment option. According to Frost & Sullivan, Muyuan has ranked first globally in the hog farming industry in terms of production capacity and sales volume of hogs for four consecutive years since 2021. The Kirkland team included capital markets lawyers Mengyu Lu, Brian Ho, George Zheng, Ryan Choi, Qingyu Wu, Rock Liu, Luna Wang and Kelly Chan.
Feb 6

1 min
Ph.D., Economics, Chinese Academy of Social Sciences
LL.M., Duke University School of Law
LL.B., China University of Political Science and Law